NYR 23.6% 10.8¢ nyrada inc.

Ann: Brain Injury Program GLP Studies Further Update, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,293 Posts.
    lightbulb Created with Sketch. 1274
    Rather a derogatory posting. From little acorns big oak trees grow. They are proceeding in a logical manner and you start small. They know what they are doing, indeed the MD/CEO? was on the Neuren team when it was 10c on a good day and through their logical small start, methodical approach that stock went to $10+.
    Whilst we are doing the GLP preliminary work The US Army Walter Reed Centre is undergoing testwork as well and we should get a readout before too long, And yes, WR use rat(s) as well. WR is the LEADING brain injury research Centre in the USA. A positive result from their prelim work will hold us in good stead for FDA approval to go to Phase 1/2. After all, who would disagree with the US Army ! As for funding, an all clear from WR and no GLP issues would I expectasily funding from the US Army and/ or other agencies in the USA. The US Army has said Traumatic Brain Injury is their Number 1 issue when it comes to medical research. The risk/reward scenarion here is too compelling to ignore.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.